Comparison between AB Cotspin IPO and Fabino Life Sciences IPO.
AB Cotspin IPO is a SME Fixed Price IPO proposed to list at NSE SME while Fabino Life Sciences IPO is a SME Fixed Price proposed to list at BSE SME.
| AB Cotspin IPO | Fabino Life Sciences IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt.Ltd. | Aryaman Financial Services Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Pentagon Stock Brokers Pvt.Ltd. | Aryaman Capital Markets Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of AB Cotspin IPO is up to ₹9.58 Cr whereas the issue size of the Fabino Life Sciences IPO is up to ₹3.07 Cr. The final issue price of AB Cotspin IPO is ₹35.00 per share and of Fabino Life Sciences IPO is ₹36.00 per share.
| AB Cotspin IPO | Fabino Life Sciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹33.00 per share | |
| Issue Price (Upper) | ₹35.00 per share | |
| Issue Price (Final) | ₹35.00 per share | ₹36.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 3000 shares |
| Fresh Issue Size | 27,36,000 shares | 8,52,000 shares |
| Fresh Issue Size (Amount) | up to ₹9.58 Cr | up to ₹3.07 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 27,36,000 shares | 8,52,000 shares |
| Issue Size Total (Amount) | up to ₹9.58 Cr | up to ₹3.07 Cr |
AB Cotspin IPO opens on Dec 30, 2021, while Fabino Life Sciences IPO opens on Dec 31, 2021. The closing date of AB Cotspin IPO and Fabino Life Sciences IPO is Jan 03, 2022, and Jan 05, 2022, respectively.
| AB Cotspin IPO | Fabino Life Sciences IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Dec 30, 2021 | Dec 31, 2021 |
| Issue Close | Jan 03, 2022 | Jan 05, 2022 |
| Basis Of Allotment (Tentative) | Jan 06, 2022 | Jan 10, 2022 |
| Initiation of Refunds (Tentative) | Jan 07, 2022 | Jan 11, 2022 |
| Credit of Share (Tentative) | Jan 10, 2022 | Jan 12, 2022 |
| Listing date (Tentative) | Jan 11, 2022 | Jan 13, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
AB Cotspin IPO P/E ratio is 2.71, as compared to Fabino Life Sciences IPO P/E ratio of 133.
| AB Cotspin IPO | Fabino Life Sciences IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 48.50 | 99.43 | ||||
| Promoter Shareholding (Post-Issue) | 34.91 | 56.82 | ||||
| P/E Ratio | 2.71 | 133 | ||||
| Market Cap | ₹36.02 Cr. | ₹7.56 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the AB Cotspin IPO Retail Individual Investors (RII) are offered 13,68,000 shares while in Fabino Life Sciences IPO retail investors are offered 13,68,000 shares. Qualified Institutional Buyers (QIB) are offered in AB Cotspin IPO and in Fabino Life Sciences IPO.
| AB Cotspin IPO | Fabino Life Sciences IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,48,000 shares | 48,000 shares |
| QIB | ||
| NII | 13,68,000 shares | 4,26,000 shares |
| RII | 13,68,000 shares | 4,26,000 shares |
| Employee | ||
| Others | ||
| Total | 27,36,000 shares | 8,52,000 shares |
AB Cotspin IPO subscribed 13.46x in total, whereas Fabino Life Sciences IPO subscribed 6.93x.
| AB Cotspin IPO | Fabino Life Sciences IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 9.45x | 3.49x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 17.47x | 10.36x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 13.46x | 6.93x |
